Novel Cyanopyrimidine Derivatives as Potential Anticancer Agents
Molecules · 2025
DOI: 10.3390/molecules30071453 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Rania H Abd El-Hameed und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Helwan University, Cairo 11795, Egypt. Hauptthemen laut MEDLINE: Antineoplastic Agents, Pyrimidines. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taif University, Taif University, Saudi Arabia.
Abstract (Originalsprache)
The Bcl-2 family’s anti-apoptotic proteins, particularly Mcl-1, offer a viable avenue for cancer treatment since cancer cells can undergo apoptosis when their selective suppression occurs. Mcl-1 is essential for controlling the advancement of the cell cycle, as well as apoptosis. There is a constant clinical need for more potent treatments for breast and ovarian malignancies, even with advancements in the discovery of anticancer drugs. By synthesizing cyanopyrimidine derivatives that demonstrate both dual inhibitory activity against Mcl-1 and Bcl-2, and successful cell cycle arrest, our research seeks to contribute to the development of innovative therapeutic medicines. We created a number of new 6-substituted cyanopyrimidines and tested their anticancer effects on SKOV-3 and MCF-7 cell lines as well as apoptosis and cell cycle arrest assays.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Helwan University, Cairo 11795, Egypt.
- Medical Biochemistry Department, National Research Centre, Dokki 12622, Egypt.
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif 21944, Saudi Arabia.
- Department of Reproductive Health Research and Family Planning, National Research Centre, Dokki 12622, Egypt.
- Department of Chemistry, The State University of New York, Buffalo, NY 14260, USA.
- Biochemistry and Molecular Biology Department, Faculty of Pharmacy, Helwan University, Cairo 11795, Egypt.
ORCID-Profile: Omnia Aly, Amal F Gharib, Ashraf Ali, Zainab M Khoder, Heba Taha, Samar S Fatahala
Förderung
- Taif University
- Taif University, Saudi Arabia
Zitieren
APA
Abd El-Hameed, R. H., Aly, O., Mohamed, M. E., Gharib, A. F., Mohamed, M. S., Ali, A., Khoder, Z. M., Taha, H., & Fatahala, S. S. (2025). Novel Cyanopyrimidine Derivatives as Potential Anticancer Agents. Molecules. https://doi.org/10.3390/molecules30071453
Vancouver
Abd El-Hameed RH, Aly O, Mohamed ME, Gharib AF, Mohamed MS, Ali A, et al. Novel Cyanopyrimidine Derivatives as Potential Anticancer Agents. Molecules. 2025. doi:10.3390/molecules30071453
BibTeX
@article{AbdElHameed2025,
author = {Abd El-Hameed, Rania H and Aly, Omnia and Mohamed, Mariem E and Gharib, Amal F and Mohamed, Mosaad S and Ali, Ashraf and Khoder, Zainab M and Taha, Heba and Fatahala, Samar S},
title = {Novel Cyanopyrimidine Derivatives as Potential Anticancer Agents},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30071453}
}
EUVIMED